Curaleaf Holdings (CURLF) Return on Sales (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Return on Sales of 0.0% for Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 98.13% on a QoQ basis from 0.0% in Q4 2025.
Curaleaf Holdings (CURLF) Return on Sales (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Return on Sales for 8 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales improved to 0.0% in Q1 2026 per CURLF's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Sales for CURLF reached as high as 0.0% in Q1 2022 and fell as low as 231.56% in Q4 2023.
- A 5-year average of 13.62% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales sank 23156 bps — and 2024, when it surged 23156 bps.
- Year by year, Return on Sales stood at 0.0% in 2022, then sank by 9418984 bps to 231.56% in 2023, then jumped by 100 bps to 0.0% in 2024, then slumped by 38 bps to 0.0% in 2025, then soared by 98 bps to 0.0% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -0.01% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -231.56% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |